Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-18-013863
Filing Date
2018-09-28
Accepted
2018-09-28 11:57:15
Documents
54
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1287148
2 ex3-5.htm EX-3.5 2026
3 ex4-1.htm EX-4.1 95236
4 ex4-2.htm EX-4.2 93629
5 ex10-6.htm EX-10.6 13522
6 ex31-1.htm EX-31.1 20306
7 ex31-2.htm EX-31.2 19492
8 ex32-1.htm EX-32.1 6486
9 ex32-2.htm EX-32.2 6650
10 image_001.jpg GRAPHIC 7458
11 ex3-5_001.jpg GRAPHIC 101564
12 ex3-5_002.jpg GRAPHIC 113468
  Complete submission text file 0001493152-18-013863.txt   3785647

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE FILE ntva-20180630.xml EX-101.INS 300064
14 XBRL SCHEMA FILE ntva-20180630.xsd EX-101.SCH 39011
15 XBRL CALCULATION FILE ntva-20180630_cal.xml EX-101.CAL 28356
16 XBRL DEFINITION FILE ntva-20180630_def.xml EX-101.DEF 135180
17 XBRL LABEL FILE ntva-20180630_lab.xml EX-101.LAB 248115
18 XBRL PRESENTATION FILE ntva-20180630_pre.xml EX-101.PRE 183912
Mailing Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246
Business Address 4340 E KENTUCKY AVE SUITE 206 GLENDALE CO 80246 3034957583
NEXIEN BIOPHARMA, INC. (Filer) CIK: 0001625288 (see all company filings)

EIN.: 262049376 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-55320 | Film No.: 181093139
SIC: 2834 Pharmaceutical Preparations